Interaction of calcium channel blockers and grapefruit juice in healthy adults
References
Additional references
Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clinical Pharmacology and Therapeutics 1993;54:589‐94.
Bailey DG, Arnold JMO, Bend JR, Tran LT, Spence JD. Grapefruit juice‐felodipine interaction: reproducibility and characterization with the extended drug release formulation. British Journal of Clinical Pharmacology 1995;40:135‐40.
Dahan A, Altman H. Food‐drug interaction: grapefruit juice augments drug bioavailability‐mechanism, extent and relevance. European Journal of Clinical Nutrition 2004;58:1‐9.
Eagling VA, Profit L, Back DJ. Inhibition of the CYP3A4 mediated metabolism and p‐glycoprotein mediated transport of the HIV‐1 protease inhibitor saquinavir by grapefruit juice components. British Journal of Clinical Pharmacology 1999;48:543‐52.
Edwards DJ, Bellevue FH, Woster PM. Identification of 6',7'‐dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metabolism and Disposition 1996;24:1287‐90.
Egger M, Davey‐Smith G, Schneider M, Minder CSO. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;13:629‐34.
Fellers PJ, Nikdel S, Lee HS. Nutrition content and nutrition labeling of several processed Florida citrus juice products. Journal of the American Dietetic Association 1990;90:1079‐84.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0. Available from www.cochrane‐handbook.org, updated March 2011.
Kiani J, Imam SZ. Medicinal importance of grapefruit juice and its interaction with various drugs. Nutrition Journal 2007;6:33. [DOI: 10.1186/1475‐2891‐6‐33]
Kolars JC, Schmiedlin‐Ren P, Schuetz JD, Fang C, Watkins PB. Identification of rifampicin inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. Journal of Clinical Investigation 1992;90:1871‐8.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. [DOI: http://dx.doi.org/10.1136/bmj.b2700]
Lilja JJ, Kivisto KT, Backman JT, Neuvonen PJ. Effect of grapefruit juice dose on grapefruit juice‐triazolam interaction: repeated consumption prolongs triazolam half‐life. European Journal of Clinical Pharmacology 2000;56:411‐5.
Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortiage LA, et al. Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression. Journal of Clinical Investigation 1997;99:2545‐53.
McDonagh MS, Eden KB, Peterson K. Drug Class Review on Calcium Channel Blockers: Final Report. Portland (OR): Oregon Health & Science University, March 2005.
Michel T, Hoffman BB. Treatment of myocardial ischemia and hypertension. In: Brunton LL, Chabner BA, Knollmann BC editor(s). The Pharmacological Basis of Therapeutics. 12th Edition. McGraw Hill, 2011:759.
Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition of dihydropyrimidine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. Journal of Pharmacology and Experimental Therapeutics 1992;261:1195‐9.
Ohnishi A, Ohtani H, Sawada Y. Major determinant factors of the extent of interaction between grapefruit juice and calcium channel antagonists. British Journal of Clinical Pharmacology 2006;62:196‐9.
Ozdemir M, Aktan Y, Boydag BS, Cingi MI, Musmul A. Interaction between grapefruit juice and diazepam in humans. European Journal of Drug Metabolism and Pharmacokinetics 1998;23:55‐9.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Sica DA. Heterogeneity: select aspects of pharmacokinetics and pharmacodynamics. Journal of Clinical Hypertension 2005;7:21‐6.
Sica DA. Pharmacotherapy review: calcium channel blockers. Journal of Clinical Hypertension 2006;8:53‐6.
Sterling ES, Smith KM. What's the scoop with grapefruit?. Orthopedics 2005;28:31‐4.
Takanaga H, Ohnishi A, Matsuo H, Sawada Y. Inhibition of vinblastine efflux mediated by p‐glycoprotein by grapefruit juice components in Caco‐2 cells. Biological and Pharmaceutical Bulletin 1998;21:1062‐6.
Talbert RL, Bussey HI. Update on calcium channel blocking agents. Clinical Pharmacy 1983;2:403‐16.
Uno T, Ohkubo T, Motomura S, Sugawara K. Effect of grapefruit juice on the disposition of manidipine enantiomers in healthy subjects. British Journal of Clinical Pharmacology 2006;61:533‐7.
